CAR T-Cell Therapy - Patient Education

Car T-Cell Therapy
PATIENT EDUCATION

  • Home
  • Preparing for CAR T-Cell Therapy
    • Your Care Team
    • Evaluation Tests and Screening
    • Financial and Insurance Planning
    • Identifying a Caregiver
    • Short-Term Accommodations
    • Psychosocial Support
  • Steps of CAR T-cell Therapy
    • Step 1: Cell Collection
    • Step 2: CAR T-Cell Manufacturing
    • Step 3: Bridging Therapy
    • Step 4: Preparative Chemotherapy
    • Step 5: CAR T-Cell Infusion
  • Side Effects
  • Receiving CAR T-Cell Therapy in the Hospital
  • Receiving CAR T-Cell Therapy in the Outpatient Clinic
  • Recovering from CAR T-Cell Therapy
    • Infection Precautions
    • Nutrition
    • Physical Activity
  • When to Call Your Care Team
  • For Caregivers
  • Resources
  • Contact Information

Physical Activity

You will likely feel very tired after CAR T-cell therapy. It is important to try to do some type of mild physical exercise daily.

Tips for managing fatigue
  • Balance your rest and activity levels. Schedule time to rest between activities or exercise. In short, don’t overdo it.
  • Avoid exercise if you have a fever or don’t feel well. Exercise can further raise your body temperature and deplete your energy
  • Slowly (and safely) increase your activity level as you feel better. Exercise builds strength and extends your energy level.
  • Avoid strenuous/vigorous activities while you have a central line.
  • Focus your energy on the things that are the most important to you. Postpone or avoid non-essential activities.
  • Avoid general exercise if you have platelet counts below 10,000.
  • Avoid resistive/aggressive exercise if you have platelet counts below 20,000.
  • Take short naps (approx. 30 minutes) early in the day or at times that won’t interfere with your nighttime sleep which is important for your recovery.
          Home | Evaluation & Treatment | Side Effects | Recovery after Discharge | For Caregivers | Resources | Important Contact Information | For Clinicians
© 2018 CAR T-Cell Therapy at Dana-Farber Cancer Institute